Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction

Haematologica

Volumn 87, Issue 7, 2002, Pages 740-745

  Réganon, Edelmiro ^a   Vila, Virtudes ^a   Martínez Sales, Vicenta ^a   Vaya, Amparo ^a   Aznar, Justo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

C reactive protein; Fibrinogen; Inflammation; Myocardial infarction; Sialic acid; Thrombin generation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; SIALIC ACID; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; THROMBOSIS; BLOOD; CASE CONTROL STUDY; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBIN;

EID: 0036070558     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The pathogenesis of coronary artery disease and the acute coronary syndromes
2. The pathogenesis of atherosclerosis: A perspective for the 1990s
3. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
4. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
5. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes
6. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
7. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
8. Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction
9. Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients
10. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks
11. Acute-phase proteins and other systemic responses to inflammation
12. Atherosclerosis: An inflammatory disease
13. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: A long-term cohort study
14. Serum sialic acid concentration and cardiovascular mortality
15. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
16. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
17. Production of C-reactive protein and risk of coronary events in stable and unstable angina
18. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
19. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction
20. Serum total and lipid-bound sialic acid levels following acute myocardial infarction
21. Thrombogenic factors and recurrent coronary events
22. Elevated thrombotic activity after myocardial infarction: A two-year follow-up study
23. Simple method for detection of abnormal plasma fibrinogen levels
24. Gelification of fibrinogen in plasma. A kinetic study by turbidity measurement
25. Fibrinogen: A vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cells
26. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC Investigators. Atherosclerosis Risk in Communities Study
27. Generation of C-reactive protein and complement components in atherosclerotic plaques
28. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis
29. Tissue factor in atherosclerosis
30. Tissue factor modulates the thrombogenicity in human atherosclerotic plaques